Form 4: NHC Director Exercises Stock Options, Adjusts Holdings

National Healthcare Corp Director James Paul Abernathy exercised stock options and sold shares to cover the exercise price, adjusting his direct beneficial ownership.

Summary

• Director James Paul Abernathy, a Director of National Healthcare Corp (NHC), reported transactions on January 15, 2026.
• Exercised 7,500 options to purchase common stock at an exercise price of $69.82 per share. These options were granted on May 5, 2022, under the 2020 Omnibus Equity Incentive Plan.
• Disposed of 3,732 shares of common stock at $139.01 per share to cover the exercise price of the options.
• Following these transactions, Abernathy directly beneficially owns 40,162 shares of common stock.
• He also holds unexercised options for 7,500 shares each from 2023, 2024, and 2025 grants, with varying exercise prices and expiration dates.

Sentiment

Score: 6

Explanation: The filing reports a routine insider transaction where a director exercised stock options and sold a portion of the acquired shares to cover the exercise price. This is a standard practice and does not indicate significant positive or negative sentiment beyond the director realizing value from previously granted equity.

Positives

• Director exercised options, indicating a realization of value from previously granted equity compensation.
• The exercise price of $69.82 is significantly lower than the disposition price of $139.01, suggesting a substantial in-the-money gain for the director on the exercised options.

Negatives

• A portion of the acquired shares (3,732 shares) was disposed of to cover the exercise price, which is a common practice but reduces the director's direct ownership post-exercise.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Director James Paul Abernathy exercised stock options granted by National Healthcare Corp under its 2020 Omnibus Equity Incentive Plan.
• National Healthcare Corp withheld 3,732 shares of common stock from the director to cover the exercise price of the options.

Stakeholder Impact

• Shareholders: The transaction represents a director realizing value from their equity compensation, which can be viewed as a positive signal of management's alignment with shareholder interests, though it also involves a slight reduction in the director's direct shareholding post-exercise due to tax withholding.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where a director exercised stock options and sold shares to cover the exercise price. Such transactions are common and do not typically signal a fundamental change in the company's prospects or valuation. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

NHC, National Healthcare Corp, Stock Options, Insider Transaction, Form 4, Director Holdings, Equity Incentive Plan, Beneficial Ownership